Home  >  Products  >  RBBP9 (retinoblastoma binding protein 9) Blocking Peptide (the N terminal of protein) (100ug)
RBBP9 (retinoblastoma binding protein 9) Blocking Peptide (the N terminal of protein) (100ug)

RBBP9 (retinoblastoma binding protein 9) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RBBP9 antibody (Catalogue #: ARP34703_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP34703
Size: 100 ug
Weight: 21kDa
Gene: 10741
Format: Lyophilized powder
Target: RBBP9 may play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.The protein encoded by this gene is a retinoblastoma binding protein that may play a role in the regulation of cell proliferation and differentiation. Two alternatively spliced transcript variants of this gene with identical predicted protein products have been reported, one of which is a nonsense-mediated decay candidate.
Alternative names: BOG; MGC9236; RBBP10
See Full Product Listings >